The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity
- PMID: 12427744
- DOI: 10.1074/jbc.M210665200
The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity
Abstract
An anti-human interleukin 5 receptor (hIL-5R) humanized immunoglobulin G1 (IgG1) and an anti-CD20 chimeric IgG1 produced by rat hybridoma YB2/0 cell lines showed more than 50-fold higher antibody-dependent cellular cytotoxicity (ADCC) using purified human peripheral blood mononuclear cells as effector than those produced by Chinese hamster ovary (CHO) cell lines. Monosaccharide composition and oligosaccharide profiling analysis showed that low fucose (Fuc) content of complex-type oligosaccharides was characteristic in YB2/0-produced IgG1s compared with high Fuc content of CHO-produced IgG1s. YB2/0-produced anti-hIL-5R IgG1 was subjected to Lens culinaris aggulutin affinity column and fractionated based on the contents of Fuc. The lower Fuc IgG1 had higher ADCC than the IgG1 before separation. In contrast, the content of bisecting GlcNAc of the IgG1 affected ADCC much less than that of Fuc. In addition, the correlation between Gal and ADCC was not observed. When the combined effect of Fuc and bisecting GlcNAc was examined in anti-CD20 IgG1, only a severalfold increase of ADCC was observed by the addition of GlcNAc to highly fucosylated IgG1. Quantitative PCR analysis indicated that YB2/0 cells had lower expression level of FUT8 mRNA, which codes alpha1,6-fucosyltransferase, than CHO cells. Overexpression of FUT8 mRNA in YB2/0 cells led to an increase of fucosylated oligosaccharides and decrease of ADCC of the IgG1. These results indicate that the lack of fucosylation of IgG1 has the most critical role in enhancement of ADCC, although several reports have suggested the importance of Gal or bisecting GlcNAc and provide important information to produce the effective therapeutic antibody.
Similar articles
-
Comparison of cell lines for stable production of fucose-negative antibodies with enhanced ADCC.Biotechnol Bioeng. 2006 Jul 5;94(4):680-8. doi: 10.1002/bit.20880. Biotechnol Bioeng. 2006. PMID: 16609957
-
Establishment of FUT8 knockout Chinese hamster ovary cells: an ideal host cell line for producing completely defucosylated antibodies with enhanced antibody-dependent cellular cytotoxicity.Biotechnol Bioeng. 2004 Sep 5;87(5):614-22. doi: 10.1002/bit.20151. Biotechnol Bioeng. 2004. PMID: 15352059
-
Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types.Glycobiology. 2007 Jan;17(1):104-18. doi: 10.1093/glycob/cwl057. Epub 2006 Sep 29. Glycobiology. 2007. PMID: 17012310
-
[Potelligent antibodies as next generation therapeutic antibodies].Yakugaku Zasshi. 2009 Jan;129(1):3-9. doi: 10.1248/yakushi.129.3. Yakugaku Zasshi. 2009. PMID: 19122430 Review. Japanese.
-
Antibody glycosylation and its impact on the pharmacokinetics and pharmacodynamics of monoclonal antibodies and Fc-fusion proteins.J Pharm Sci. 2015 Jun;104(6):1866-1884. doi: 10.1002/jps.24444. Epub 2015 Apr 14. J Pharm Sci. 2015. PMID: 25872915 Review.
Cited by
-
Novel asymmetrically engineered antibody Fc variant with superior FcγR binding affinity and specificity compared with afucosylated Fc variant.MAbs. 2013 Mar-Apr;5(2):229-36. doi: 10.4161/mabs.23452. Epub 2013 Feb 13. MAbs. 2013. PMID: 23406628 Free PMC article.
-
Glycoengineered Monoclonal Antibodies with Homogeneous Glycan (M3, G0, G2, and A2) Using a Chemoenzymatic Approach Have Different Affinities for FcγRIIIa and Variable Antibody-Dependent Cellular Cytotoxicity Activities.PLoS One. 2015 Jul 22;10(7):e0132848. doi: 10.1371/journal.pone.0132848. eCollection 2015. PLoS One. 2015. PMID: 26200113 Free PMC article.
-
Systematic analysis of Fc mutations designed to enhance binding to Fc-gamma receptors.MAbs. 2024 Jan-Dec;16(1):2406539. doi: 10.1080/19420862.2024.2406539. Epub 2024 Sep 22. MAbs. 2024. PMID: 39306747 Free PMC article.
-
Phase 1 Study of CEP-37250/KHK2804, a Tumor-specific Anti-glycoconjugate Monoclonal Antibody, in Patients with Advanced Solid Tumors.Target Oncol. 2016 Dec;11(6):807-814. doi: 10.1007/s11523-016-0449-2. Target Oncol. 2016. PMID: 27457707 Clinical Trial.
-
Chemoenzymatic glycoengineering of intact IgG antibodies for gain of functions.J Am Chem Soc. 2012 Jul 25;134(29):12308-18. doi: 10.1021/ja3051266. Epub 2012 Jul 16. J Am Chem Soc. 2012. PMID: 22747414 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources